Validity of Self-Reported Drug Use Information Among Pregnant Women

Maternal and Child Health Journal

Volumn 20, Issue 1, 2016, Pages 41-47

  Garg, Mahek ^a   Garrison, Laura ^a   Leeman, Lawrence ^b   Hamidovic, Ajna ^a   Borrego, Matthew ^a   Rayburn, William F ^b   Bakhireva, Ludmila ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Drug use; Pregnancy; Self report; Validity

Indexed keywords

ADULT; COHORT ANALYSIS; FEMALE; HUMAN; NEW MEXICO; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDY; PSYCHOLOGY; SELF REPORT; STANDARDS; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS; TRENDS;

ADULT; COHORT STUDIES; FEMALE; HUMANS; NEW MEXICO; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDIES; SELF REPORT; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 84954290501     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-015-1799-6     Document Type: Article

References (38)

1. Babor, T. F., Steinberg, K., Anton, R., & Del Boca, F. (2000). Talk is cheap: Measuring drinking outcomes in clinical trials. Journal of Studies on Alcohol,61(1), 55–63.
2. Bakhireva, L. N., Cano, S., Rayburn, W. F., Savich, R. D., Leeman, L., Anton, R. F., & Savage, D. D. (2012). Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women. Alcohol and Alcoholism,47(6), 683–687. doi:10.1093/alcalc/ags087.
3. Bakhireva, L. N., Leeman, L., Savich, R. D., Cano, S., Gutierrez, H., Savage, D. D., & Rayburn, W. F. (2014). The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposure. Alcoholism, Clinical and Experimental Research,38(4), 1078–1085. doi:10.1111/acer.12349.
4. Bar-Oz, B., Klein, J., Karaskov, T., & Koren, G. (2003). Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Archives of Disease in Childhood-Fetal and Neonatal Edition,88(2), F98–f100.
5. Bibb, K. W., Stewart, D., Walker, J. R., Cook, V. D., & Wagener, R. E. (1994). Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews. Journal of Perinatology: Official Journal of the California Perinatal Association,15(3), 199–202.
6. Carlson, R. (2014). A gap in the criminal justice system, creating a new class of felons in pregnant drug-addicted women, a state-by-state analysis. Mississippi Law Journal Supra, 83, 71–100.
7. Chermack, S. T., Roll, J., Reilly, M., Davis, L., Kilaru, U., & Grabowski, J. (2000). Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug and Alcohol Dependence,59(1), 43–49.
8. Christmas, J. T., Knisely, J. S., Dawson, K. S., Dinsmoor, M. J., Weber, S. E., & Schnoll, S. H. (1992). Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstetrics and Gynecology,80(5), 750–754.
9. Del Boca, F. K., & Noll, J. A. (2000). Truth or consequences: The validity of self-report data in health services research on addictions. Addiction,95(Suppl 3), S347–S360.
10. Delaney-Black, V., Chiodo, L. M., Hannigan, J. H., Greenwald, M. K., Janisse, J., Patterson, G., & Sokol, R. J. (2010). Just say “I don’t”: Lack of concordance between teen report and biological measures of drug use. Pediatrics,126(5), 887–893. doi:10.1542/peds.2009-3059.
11. Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstetrics and Gynecology,123(5), 997–1002.
12. El Marroun, H., Tiemeier, H., Jaddoe, V., Hofman, A., Verhulst, F., van den Brink, W., & Huizink, A. (2010). Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: The generation R study. European Addiction Research,17(1), 37–43.
13. Greenfield, T. K., Nayak, M. B., Bond, J., Kerr, W. C., & Ye, Y. (2014). Test-retest reliability and validity of life-course alcohol consumption measures: The 2005 National Alcohol Survey follow-up. Alcoholism, Clinical and Experimental Research,38(9), 2479–2487. doi:10.1111/acer.12480.
14. Harrell, A. V. (1997). The validity of self-reported drug use data: The accuracy of responses on confidential self-administered answered sheets. NIDA Research Monograph,167, 37–58.
15. Harrison, L. (1997). The validity of self-reported drug use in survey research: An overview and critique of research methods. NIDA Research Monograph,167, 17–36.
16. Horrigan, T. J., & Piazza, N. (1999). The substance abuse subtle screening inventory minimizes the need for toxicology screening of prenatal patients. Journal of Substance Abuse Treatment,17(3), 243–247.
17. Jain, R., Balhara, Y. P., Jhanjee, S., & Sethi, H. (2012). Concordance between urinary cotinine levels and self-reported tobacco use among drug-dependent persons: A pilot study. Substance Abuse,33(2), 99–102. doi:10.1080/08897077.2011.630947.
18. Jain, R., Quraishi, R., Majumder, P., & Pattanayak, R. D. (2013). Comparison of self-report and biological measures for alcohol, tobacco and illicit drug use in consecutive alcohol-dependent patients visiting a tertiary care centre. Journal of Substance Use,18(4), 302–310. doi:10.3109/14659891.2012.674625.
19. Lambert, B., Scheiner, M., & Campbell, D. (2010). Ethical issues and addiction. Journal of Addictive Diseases,29(2), 164–174. doi:10.1080/10550881003684673.
20. Lange, S., Shield, K., Koren, G., Rehm, J., & Popova, S. (2014). A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: A systematic literature review and meta-analysis. BMC Pregnancy Childbirth,14, 127. doi:10.1186/1471-2393-14-127.
21. Lundahl, B., & Burke, B. L. (2009). The effectiveness and applicability of motivational interviewing: A practice-friendly review of four meta-analyses. Journal of Clinical Psychology,65(11), 1232–1245. doi:10.1002/jclp.20638.
22. Mabe, P. A., & West, S. G. (1982). Validity of self-evaluation of ability: A review and meta-analysis. Journal of Applied Psychology,67(3), 280–296. doi:10.1037/0021-9010.67.3.280.
23. Melanson, S. E. (2012). The utility of immunoassays for urine drug testing. Clinics in Laboratory Medicine,32(3), 429–447. doi:10.1016/j.cll.2012.06.004.
24. Musshoff, F., Driever, F., Lachenmeier, K., Lachenmeier, D., Banger, M., & Madea, B. (2006). Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests. Forensic Science International,156(2), 118–123.
25. Poland, M. L., Dombrowski, M. P., Ager, J. W., & Sokol, R. J. (1993). Punishing pregnant drug users: Enhancing the flight from care. Drug and Alcohol Dependence,31(3), 199–203. doi:10.1016/0376-8716(93)90001-7.
26. Reisfield, G. M., Salazar, E., & Bertholf, R. L. (2007). Rational use and interpretation of urine drug testing in chronic opioid therapy. Annals of Clinical and Laboratory Science,37(4), 301–314.
27. SAMHSA. (2011). National Survey on Drug Use and Health, 2011. doi:10.3886/ICPSR34481.v3.
28. SAMHSA. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings.
29. Schauberger, C. W., Newbury, E. J., Colburn, J. M., & Al-Hamadani, M. (2014). Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting. American Journal of Obstetrics and Gynecology,211(3), 255. doi:10.1016/j.ajog.2014.03.023.
30. Sim, J., & Wright, C. C. (2005). The kappa statistic in reliability studies: Use, interpretation, and sample size requirements. Physical Therapy,85(3), 257–268.
31. Stone-Manista, K. (2009). Protecting pregnant women: A guide to successfully challenging criminal child abuse prosecutions of pregnant drug addicts. The Journal of Criminal Law and Criminology,99(3), 823–856. doi:10.2307/20685059.
32. Tourangeau, R., & Yan, T. (2007). Sensitive questions in surveys. Psychological Bulletin,133(5), 859.
33. Viera, A. J., & Garrett, J. M. (2005). Understanding interobserver agreement: The kappa statistic. Family Medicine,37(5), 360–363.
34. Voils, C. I., Maciejewski, M. L., Hoyle, R. H., Reeve, B. B., Gallagher, P., Bryson, C. L., & Yancy, W. S, Jr. (2012). Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Medical Care,50(12), 1013–1019. doi:10.1097/MLR.0b013e318269e121.
35. Weber, E. M. (1993). Alcohol-and drug-dependent pregnant women: Laws and public policies that promote and inhibit research and the delivery of services. NIDA Research Monograph,117, 349.
36. Wendell, A. D. (2013). Overview and epidemiology of substance abuse in pregnancy. Clinical Obstetrics and Gynecology,56(1), 91–96. doi:10.1097/GRF.0b013e31827feeb9.
37. Winstock, A. R., Lea, T., & Sheridan, J. (2008). Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. International Journal of Drug Policy,19, 450–458.
38. Yonkers, K. A., Howell, H. B., Gotman, N., & Rounsaville, B. J. (2011). Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women. Journal of Substance Use,16(5), 372–389. doi:10.3109/14659891003721133.